As of September 2023 Sino Biopharmaceutical has a market cap of $6.85 Billion. This makes Sino Biopharmaceutical the world's 1982th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2023 | $6.85 B | -38.31% |
2022 | $11.10 B | -15.8% |
2021 | $13.18 B | -28.2% |
2020 | $18.36 B | 4.26% |
2019 | $17.61 B | 112.09% |
2018 | $8.30 B | -36.79% |
2017 | $13.14 B | 151.84% |
2016 | $5.21 B | -22.71% |
2015 | $6.75 B | 50.75% |
2014 | $4.47 B | 14.28% |
2013 | $3.91 B | 66.15% |
2012 | $2.35 B | 60.61% |
2011 | $1.46 B | -20.21% |
2010 | $1.84 B | 26.08% |
2009 | $1.45 B | 374.58% |
2008 | $0.30 B | -26.93% |
2007 | $0.42 B | 57.15% |
2006 | $0.26 B | -42.29% |
2005 | $0.46 B | 65.82% |
2004 | $0.27 B |
On Sep 26th, 2023 the market cap of Sino Biopharmaceutical was reported to be: